Evaluation of the Effects of the Tritordeum-Based Diet Compared to the Low-FODMAPs Diet on the Fecal Metabolome of IBS-D Patients: A Preliminary Investigation.
Tritordeum
diet
functional gastrointestinal disorders
irritable bowel syndrome
metabolome
short-chain fatty acids
volatile organic compounds
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
02 Nov 2022
02 Nov 2022
Historique:
received:
03
10
2022
revised:
31
10
2022
accepted:
01
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Since irritable bowel syndrome (IBS)-a common gastrointestinal (GI) disorder-still lacks effective therapy, a nutritional approach may represent a practical alternative. Different reports demonstrated that a low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) diet (LFD) reduces symptoms in IBS with diarrhea (IBS-D) patients, also inducing beneficial pathophysiological and biochemical modifications. More recently, diets with alternative cereals having a different gluten composition, such as tritordeum, have also been considered (TBD). We investigated the impact of TBD and LFD on the fecal metabolome composition in 38 IBS-D patients randomly allocated to the two diets for 12 weeks. Summarily, at baseline, the profile of fecal volatile organic compounds (VOCs) of IBS-D patients was not significantly different in the two groups. After treatment, significant changes were observed in the two groups regarding the VOCs content since some of them increased in the TBD group (namely, decanoic acid), whereas others (i.e., nonanal and ethanol) increased in the LFD one. Further, at baseline, short-chain fatty acids were positively related to inflammation and showed a significant decreasing trend after both diets compared to baseline values (namely, acetic and propanoic acid). Preliminary results from this pilot study suggest a potential positive intervention of TBD and LFD affecting the fecal metabolome composition in IBS-D patients.
Identifiants
pubmed: 36364888
pii: nu14214628
doi: 10.3390/nu14214628
pmc: PMC9657445
pii:
doi:
Substances chimiques
Monosaccharides
0
Disaccharides
0
Oligosaccharides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Ministry of Health
ID : RC 2020-2021, Prog. N° 16 (DDG n. 700/2020).
Références
Neurogastroenterol Motil. 2010 May;22(5):512-9, e114-5
pubmed: 19903265
Nutrients. 2017 Aug 26;9(9):
pubmed: 28846594
Eur J Clin Invest. 2020 Mar;50(3):e13201
pubmed: 31960952
Nutrients. 2020 Jun 02;12(6):
pubmed: 32498383
Clin Gastroenterol Hepatol. 2012 Jul;10(7):712-721.e4
pubmed: 22426087
J Inflamm Res. 2018 Sep 21;11:345-349
pubmed: 30288077
Nutrients. 2019 Apr 19;11(4):
pubmed: 31010241
Gut. 2004 Nov;53(11):1577-82
pubmed: 15479674
Nutrients. 2020 Aug 07;12(8):
pubmed: 32784614
J Sci Food Agric. 2021 Jun;101(8):3508-3517
pubmed: 33275797
Eur J Nutr. 2012 Sep;51(6):693-705
pubmed: 21952691
J Proteome Res. 2019 May 3;18(5):1948-1957
pubmed: 30895795
Front Immunol. 2021 Oct 12;12:694787
pubmed: 34712223
Am J Gastroenterol. 2015 Sep;110(9):1339-46
pubmed: 26303129
J Neurogastroenterol Motil. 2017 Apr 30;23(2):151-163
pubmed: 28274109
Br J Nutr. 2005 Apr;93 Suppl 1:S13-25
pubmed: 15877886
Front Nutr. 2022 Feb 15;9:797192
pubmed: 35242794
FASEB J. 2007 Jun;21(8):1675-88
pubmed: 17314143
Sci Rep. 2020 Mar 30;10(1):5681
pubmed: 32231228
Physiol Rev. 2001 Jul;81(3):1031-64
pubmed: 11427691
Int J Mol Sci. 2021 Jun 16;22(12):
pubmed: 34208638
Nutrients. 2021 Mar 21;13(3):
pubmed: 33801020
Eur J Nutr. 2016 Apr;55(3):931-40
pubmed: 25911003
New Microbiol. 2016 Jan;39(1):1-12
pubmed: 26922981
Food Res Int. 2021 Apr;142:110189
pubmed: 33773665
Sci Rep. 2017 Nov 28;7(1):16530
pubmed: 29184078
Arab J Gastroenterol. 2018 Sep;19(3):136-141
pubmed: 29935865
Aliment Pharmacol Ther. 2016 Mar;43(5):596-611
pubmed: 26806034
Aliment Pharmacol Ther. 1997 Dec;11(6):1067-72
pubmed: 9663831
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402
pubmed: 9146781
Psychopharmacology (Berl). 2022 May;239(5):1475-1486
pubmed: 34846548
Acta Naturae. 2020 Apr-Jun;12(2):4-14
pubmed: 32742723
Food Chem. 2016 Feb 1;192:714-23
pubmed: 26304402
Aliment Pharmacol Ther. 2008 Jan 15;27(2):120-45
pubmed: 17922802